Home ›
Trademark Categories ›
Pharmaceuticals ›
2017 ›
PO ›
POWRESI
Trademark search for:
POWRESI
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2017-09-29 — Application filed
2018-02-01 — Sn assigned for sect 66a appl from ib
2018-02-02 — Application filed
2018-02-07 — Application filed
2018-02-07 — Assigned to examiner
2018-02-07 — Approved for pub - principal register
2018-02-13 — Application filed
2018-02-21 — Notice of publication
2018-03-13 — Published for opposition
2018-05-29 — Registered-principal register
2018-06-28 — Grant of protection created, to be sent to ib
2018-07-09 — Final disposition recorded
2018-07-10 — Final disposition recorded
2018-07-27 — Notification processed by ib
2021-07-30 — New representative at ib received
2022-06-03 — Applicant/correspondence changes (non-responsive) entered
2022-06-03 — Teas revoke/app/change addr of atty/dom rep received
2022-06-03 — Attorney/dom.rep.revoked and/or appointed
2022-06-03 — Teas change of correspondence received
2022-06-03 — Teas change of owner address received
2022-06-03 — Teas change of domestic representatives address
2022-06-25 — New representative at ib received
2023-05-29 — Courtesy reminder - sec. 71 (6-yr) e-mailed
2024-07-09 — Teas withdrawal of attorney received-firm retains
2024-07-09 — Attorney/dom.rep.revoked and/or appointed
2024-07-09 — Teas revoke/app/change addr of atty/dom rep received
2024-07-09 — Teas change of correspondence received
2024-07-09 — Teas change of domestic representatives address
2024-10-25 — Teas section 71 & 15 received
2024-10-28 — Case assigned to post registration paralegal
2024-11-04 — Office action issued
2025-05-27 — Cancelled section 71
2025-05-27 — Cancelled section 71
2025-05-27 — Notice of cancellation sec. 71 e-mailed
2025-05-27 — Notice of cancellation sec. 71 e-mailed
2025-05-27 — Final status recorded
Owner Information
Astellas Pharma Inc.
Astellas Pharma Inc.
Astellas Pharma Inc.
Correspondent
David J. Davis Baker & McKenzie LLP
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
